The Christie NHS Foundation Trust
christie.nhs.ukTotal trials
100
Active
21
Phase 3
8
Total enrollment
19,646
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Adaptive Therapy | — | — | — | — | — | 1 | |
| Standard of Care | — | — | — | — | — | 1 | |
| Concurrent oral capecitabine chemotherapy | — | — | — | — | — | 1 | |
| Cisplatin & Gemcitabine intravenous chemotherapy | — | — | — | — | — | 1 |
Next readouts
- 2026-06
- 2028-06-01
Top conditions
- Cancer10
- Lung Cancer9
- Prostate Cancer5
- Breast Cancer5
- Ovarian Cancer4
- Sarcoma4
- Oncology3
- Cholangiocarcinoma3
Frequently asked questions about The Christie NHS Foundation Trust
- How many clinical trials does The Christie NHS Foundation Trust have on ClinicalTrials.gov?
- The Christie NHS Foundation Trust is listed as the lead sponsor on 100 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of The Christie NHS Foundation Trust's trials are in Phase 3?
- 8 of The Christie NHS Foundation Trust's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does The Christie NHS Foundation Trust focus on?
- The Christie NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Cancer, Lung Cancer, Prostate Cancer, Breast Cancer, Ovarian Cancer.
- When are The Christie NHS Foundation Trust's next clinical trial readouts?
- The Christie NHS Foundation Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy”, expected around 2026-06.